{
    "Symbol": "ABBV",
    "AssetType": "Common Stock",
    "Name": "AbbVie Inc",
    "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.",
    "CIK": "1551152",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US",
    "OfficialSite": "https://www.abbvie.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "343183426000",
    "EBITDA": "26121001000",
    "PERatio": "64.97",
    "PEGRatio": "0.458",
    "BookValue": "3.838",
    "DividendPerShare": "6.13",
    "DividendYield": "0.032",
    "EPS": "2.98",
    "RevenuePerShareTTM": "31.1",
    "ProfitMargin": "0.0971",
    "OperatingMarginTTM": "0.346",
    "ReturnOnAssetsTTM": "0.0794",
    "ReturnOnEquityTTM": "0.543",
    "RevenueTTM": "54999998000",
    "GrossProfitTTM": "41527000000",
    "DilutedEPSTTM": "2.98",
    "QuarterlyEarningsGrowthYOY": "-0.325",
    "QuarterlyRevenueGrowthYOY": "0.043",
    "AnalystTargetPrice": "199.49",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "17",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "64.97",
    "ForwardPE": "16.08",
    "PriceToSalesRatioTTM": "6.24",
    "PriceToBookRatio": "50.45",
    "EVToRevenue": "7.26",
    "EVToEBITDA": "22.09",
    "Beta": "0.618",
    "52WeekHigh": "199.95",
    "52WeekLow": "132.11",
    "50DayMovingAverage": "193.13",
    "200DayMovingAverage": "174.54",
    "SharesOutstanding": "1766340000",
    "DividendDate": "2024-11-15",
    "ExDividendDate": "2024-10-15"
}